TCL Archive NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others October 18, 1996
TCL Archive Hammer’s “March Of dollars” Starts Collecting Money; Four Year Campaign Kicks Off Oct 12 September 2, 1988
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
